Actuate Therapeutics, Inc. Common stock (ACTU) Technical Analysis
$0.74▲8.28%
Market is closed - opens 7 PM, 29 Sep 2026
Insights
- Actuate Therapeutics Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Actuate Therapeutics Inc. stock suggests that it is a good time to buy
- Based on analysis of the Moving Averages technical indicator, Actuate Therapeutics Inc. stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for Actuate Therapeutics Inc. stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 30.44 | Neutral |
Stochastic | 8.1, 3.39 | Buy |
Ultimate Oscillator | 24.89 | Buy |
Stochastic Relative Strength Index | 5.7, 1.9 | Buy |
Moving Average Convergence Divergence | -0.16, -0.1 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.87 | Sell |
20 | 1.12 | Sell |
50 | 1.17 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.86 | Sell |
20 | 1.01 | Sell |
50 | 1.23 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.87 | Sell |
20 | 1.21 | Sell |
50 | 1.33 | Sell |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.68 | Sell |
20 | 0.82 | Sell |
50 | 0.89 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.62 | Sell |
20 | 0.71 | Sell |
50 | 0.9 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 0.85 |
Resistance L2 | 0.8 |
Resistance L1 | 0.71 |
Pivot Point | 0.66 |
Support L1 | 0.57 |
Support L2 | 0.52 |
Support L3 | 0.43 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.